Research ArticleNEUROPHARMACOLOGY
Pharmacological Properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: I. Potent and Selective Histamine H3 Receptor Antagonist with Drug-Like Properties
Timothy A. Esbenshade, Gerard B. Fox, Kathleen M. Krueger, Thomas R. Miller, Chae Hee Kang, Lynne I. Denny, David G. Witte, Betty B. Yao, Liping Pan, Jill Wetter, Kennan Marsh, Youssef L. Bennani, Marlon D. Cowart, James P. Sullivan and Arthur A. Hancock
Journal of Pharmacology and Experimental Therapeutics April 2005, 313 (1) 165-175; DOI: https://doi.org/10.1124/jpet.104.078303
Timothy A. Esbenshade
Gerard B. Fox
Kathleen M. Krueger
Thomas R. Miller
Chae Hee Kang
Lynne I. Denny
David G. Witte
Betty B. Yao
Liping Pan
Jill Wetter
Kennan Marsh
Youssef L. Bennani
Marlon D. Cowart
James P. Sullivan
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleNEUROPHARMACOLOGY
Pharmacological Properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: I. Potent and Selective Histamine H3 Receptor Antagonist with Drug-Like Properties
Timothy A. Esbenshade, Gerard B. Fox, Kathleen M. Krueger, Thomas R. Miller, Chae Hee Kang, Lynne I. Denny, David G. Witte, Betty B. Yao, Liping Pan, Jill Wetter, Kennan Marsh, Youssef L. Bennani, Marlon D. Cowart, James P. Sullivan and Arthur A. Hancock
Journal of Pharmacology and Experimental Therapeutics April 1, 2005, 313 (1) 165-175; DOI: https://doi.org/10.1124/jpet.104.078303
Research ArticleNEUROPHARMACOLOGY
Pharmacological Properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: I. Potent and Selective Histamine H3 Receptor Antagonist with Drug-Like Properties
Timothy A. Esbenshade, Gerard B. Fox, Kathleen M. Krueger, Thomas R. Miller, Chae Hee Kang, Lynne I. Denny, David G. Witte, Betty B. Yao, Liping Pan, Jill Wetter, Kennan Marsh, Youssef L. Bennani, Marlon D. Cowart, James P. Sullivan and Arthur A. Hancock
Journal of Pharmacology and Experimental Therapeutics April 1, 2005, 313 (1) 165-175; DOI: https://doi.org/10.1124/jpet.104.078303
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement